The acquisition could close in the second quarter of 2021 and is subject to Federal Trade Commission approval. Hill-Rom is acquiring Bardy Diagnostics for its advanced diagnostic cardiology platform.
Hill-Rom will pay $375 million in cash, plus future payments after reaching certain commercial milestones. Hill-Rom will also acquire Bardy’s net operating losses that are around $20 million.
Bardy Diagnostics, a digital health provider of ambulatory cardiac monitoring technologies, was formed in 2013.
More articles on surgery centers:
Ohio health system acquires surgery center for $21M
2 Texas health systems suspend surgeries, others don’t
Stryker’s ASC-focused business: 3 things to know
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
